What is Eikon Therapeutics, Inc. 's change in AP?

Eikon Therapeutics, Inc. (EIKN) reported change in AP of $5.32M in Q1 2026.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

MYR GroupMYRG

$15.72M+301%

RepligenRGEN

$5.92M+188%

Travel + LeisureTNL

-$98M-40.0%

Warrior Met CoalHCC

$3.29M-78.7%

Main Street CapitalMAIN

-$19.88M+12.1%

Cabot CorporationCBT

-$61M-27.1%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's change in AP?: Eikon Therapeutics, Inc. (EIKN) reported change in AP of $5.32M in Q1 2026.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.